To evaluate the healing efficacy, a comprehensive experiment was conducted on diabetic wounds treated with various agents, including: i) PBS as negative control (NC group), ii) ROS-responsive hydrogel matrix (G group), iii) monomer copper peptides M-CuP solution (M-CuP group), iv) dimeric copper peptides D-CuP solution (D-CuP group), v) ROS-responsive hydrogel with monomer copper peptides M-CuP (G/M-CuP group), and vi) ROS-responsive hydrogel with dimeric copper peptides (G/D-CuP group)
However, the data do not explain what process this increased mitochondrial activity supports
Polymorphisms in the selenoprotein S gene and subclinical cardiovascular disease in the Diabetes Heart Study
Further work to catalogue various specific phosphoepitope induction in the downstream signalling intermediates of c-MET/HGF pathway through global phosphoproteomics analysis would be very useful
Note that TB-500 is often used or discussed as an alternative to full-length Thymosin -4, so much of the supporting research applies to the parent compound
doi: 10.3389/fneur.2019.00778 193 KnoxEGAburtoMRTessierCNagpalJClarkeGODriscollCMet al